Documentos para Download:

• DIR Abemaciclibe — Adultas com câncer de mama avançado ou metastático com HR+ e HER2-
• DIR Abirateron — Câncer de próstata metastático resistente à castração em pacientes com uso prévio de quimioterapia
• DIR Abiraterona associada à terapia de privação androgênica (TPA) — Câncer de próstata resistente à castração, metastático e virgens de quimioterapia.
• DIR Abiraterona em monoterapia ou associada ao docetaxel — Câncer de próstata sensível à castração e metastático.
• DIR Ablação térmica — Metástase hepática irressecável ou ressecável com alto risco cirúrgico do câncer de cólon e reto
• DIR Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
• DIR Active Surveillance for the Management of Localized Prostate Cancer 17-9
• DIR Adjuvant and Salvage Radiotherapy After Prostatectomy: American Society of Clinical Oncology Clinical Practice Guideline Endorsement
• DIR Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small Cell Lung Cancer
• DIR Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update
• DIR Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline
• DIR Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline
• DIR Alectinibe — Câncer de pulmão de células não pequenas localmente avançado ou metastático cujos tumores expressam rearranjo no gene ALK em pacientes não tratados previamente ou após falha com crizotinibe
• DIR Alectinibe — Câncer de pulmão não pequenas células com translocação em ALK em estágio localmente avançado ou metastático como primeira linha de tratamento
• DIR American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
• DIR American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays
• DIR American Society of Clinical Oncology Endorsement: Guideline for the Management of Fever and Neutropenia in Children with Cancer and or Undergoing Hematopoietic Stem Cell Transplantation
• DIR Analysis and review of protocols and quality standards in the diagnostic process for the detection of cervical cancer
• DIR A national clinical practice guideline on the management of localised prostate cancer
• DIR Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines
• DIR Anticorpos monoclonais (bevacizumabe, cetuximabe, panitumumabe) associados à quimioterapia — Tratamento de primeira linha do câncer colorretal metastático
• DIR Apalutamida, darolutamida e enzalutamida (associados à TPA) — Câncer de próstata resistente à castração não metastático
• DIR Apalutamida — Câncer de próstata sensível à castração e metastático.
• DIR Approach to fever assessment in ambulatory cancer patients receiving chemotherapy 12-15
• DIR Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update
• DIR ASCO Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males with Germ Cell Tumors
• DIR Assessment of the effectiveness of the intraoperative detection of the sentry ganglion in solid tumours
• DIR Bevacizumabe — Câncer de Colo de Útero Persistente, Recorrente ou Metastático
• DIR Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer
• DIR Biomarkers for Systemic Therapy in Metastatic Breast Cancer
• DIR Bladder cancer
• DIR Bladder cancer: an assessment of international practice guidelines
• DIR Bladder cancer: diagnosis and management
• DIR Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline
• DIR Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update
• DIR Brain tumours (primary) and brain metastases in over 16s
• DIR Brain tumours (primary) and brain metastases in over 16s
• DIR Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update
• DIR Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
• DIR Brigatinibe — Câncer de pulmão não pequenas células com translocação em ALK em estágio localmente avançado ou metastático como primeira linha de tratamento
• DIR Cabozantinibe — Segunda linha para pacientes com carcinoma de células renais metastático
• DIR Câncer de Pulmão
• DIR Cancer of the upper aerodigestive tract: assessment and management in people aged 16 or over
• DIR Cancer services for children and young people
• DIR Cancer survivorship care
• DIR Carcinoma de Células Renais
• DIR Carcinoma de Esôfago
• DIR Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline
• DIR Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society
• DIR Cetuximabe — Câncer colorretal metastático RAS selvagem com doença limitada ao fígado em primeira linha
• DIR Cetuximabe — Câncer de cabeça e pescoço metastático
• DIR Cetuximabe — Carcinoma espinocelular de cabeça e pescoço recidivado ou metastático
• DIR Cetuximabe — Tratamento em primeira linha de pacientes com câncer colorretal metastático com expressão de EGFR, sem mutação do gene RAS
• DIR Cetuximabe em combinação com FOLFIRI ou FOLFOX — Câncer colorretal metastático KRAS selvagem com metástases hepáticas exclusivas irresecáveis
• DIR Chemo- and Targeted Therapy for Patients With HER2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline
• DIR Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update
• DIR Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
• DIR Citologia em meio líquido — Rastreamento de câncer de colo de útero e lesões precursoras
• DIR Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline
• DIR Clinical practice guidelines for keratinocyte cancer
• DIR Clinical Practice Guidelines for the Early Diagnosis and Management of Early-Onset Colorectal Cancer
• DIR Cloridrato de erlotinibe — Câncer de pulmão de células não-pequenas avançado ou metastático mutação EGFR
• DIR Colon Cancer :Diagnosis, Treatment and Follow-Up
• DIR Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society
• DIR Continuous versus Intermittent Chemotherapy Strategies in Inoperable, Advanced Colorectal Cancer 2-6v2
• DIR CPOE in the Outpatient Oncology Setting 12-14
• DIR Criteria for appropriate use of FDG-PET in esophageal cancer
• DIR Crizotinibe — Tratamento, em primeira linha, de pacientes adultos com câncer de pulmão não pequenas células (CPNPC) avançado ALK+
• DIR Darolutamida — Câncer de próstata sensível à castração e metastático.
• DIR Definitive and Adjuvant Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline
• DIR Diretrizes Brasileiras — Rastreamento do Câncer de Colo do Útero: Parte I - Rastreamento organizado utilizando testes moleculares para detecção de DNA-HPV Oncogênico
• DIR Diretrizes Diagnósticas e Terapêuticas — Carcinoma de Células Renais
• DIR Diretrizes Diagnósticas e Terapêuticas — Tumor Cerebral no Adulto
• DIR Duration of Oxaliplatin-containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline
• DIR Durvalumabe — Câncer de pulmão Não pequenas células (CPNPC) estágio III irressecável, cuja doença Não progrediu após a terapia de quimiorradiação à base de platina
• DIR E-health systems to support cancer patients: proposal for the design of future assessment studies
• DIR EAES Rapid Guideline: Complete mesocolic excision for right-sided colon cancer
• DIR Ecobroncoscopia e ecoendoscopia em uso combinado, ou ecobroncoscopia em uso isolado — Pacientes diagnosticados com câncer de pulmão
• DIR Effective communication between registered nurses and adult oncology patients in inpatient settings (Best Practice 15(1))
• DIR Effectiveness and safety of bone suppression technology for the detection of lung cancer and indications for its use
• DIR Effective Teaching Strategies and Methods for Cancer Patient Education 20-2v2
• DIR Effective Use of Advanced Practice Nurses in the Delivery of Adult Cancer Services in Ontario 16-4
• DIR EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force
• DIR Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
• DIR Endocrine Treatment and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer Guideline and Rapid Update
• DIR Endorsement of the European Association of Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas 11-6v2
• DIR Enhancing the quality of information on colorectal and prostate cancer in the population cancer register of the Basque Country (RCE) and bibliographical review
• DIR Enzalutamida — Câncer de próstata resistente à castração metastático virgens de quimioterapia
• DIR Enzalutamida — Câncer de próstata sensível à castração e metastático.
• DIR Enzalutamida associada à TPA — Câncer de próstata resistente à castração metastático com uso prévio de docetaxel
• DIR EPIDEMIOLOGICAL ANALYSIS OF INFORMATION COLLECTED BY HOSPITAL CANCER REGISTRIES IN THE BASQUE AUTONOMOUS COMMUNITY IDENTIFICATION OF POSSIBLE IMPROVEMENTS WITH REGARD TO THE FEEDBACK AND DISSEMINATION OF RESULTS
• DIR Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
• DIR Evidence-Based Clinical Practice Guidelines for Microcystic Adnexal Carcinoma Informed by a Systematic Review
• DIR Exclusão do crizotinibe — Pacientes adultos com câncer de pulmão não pequenas células (CPNPC) avançado ou metastático ALK+
• DIR Expert Consensus on Rapid On-Site Evaluation in Diagnostic Interventional Pulmonology
• DIR Expert consensus on risk assessment and early screening for invasive fungal disease in adult patients with cancer
• DIR Fear of Cancer Recurrence Guideline 19-7
• DIR Fertility Preservation in Patients with Cancer: American Society of Clinical Oncology Guideline Update
• DIR Focal Tumour Ablation: Early-stage Primary Lung Cancer and Lung Metastases 4
• DIR Follow-up after primary therapy for endometrial cancer 4-9v2
• DIR Follow-up and Surveillance of Curatively Treated Lung Cancer Patients 26-3v2
• DIR Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement
• DIR Follow-up Care and Psychosocial Needs of Survivors of Prostate Cancer 26-4
• DIR Follow-up for Cervical Cancer 4-16v3
• DIR Gastric carcinoma
• DIR Gefitinibe — Câncer de pulmão de células não pequenas avançado ou metastático com mutação EGFR, em primeira linha
• DIR GENETIC COUNSELLING IN BREAST CANCER AND COLON CANCER
• DIR Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
• DIR Guideline for preventive chemotherapy for the control of Taenia solium taeniasis
• DIR Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
• DIR Guidelines on Management of Nausea and Vomiting and on Loss of Appetite, Anorexia, and Cachexia in Cancer
• DIR Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline
• DIR Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the Familial Risk–Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guideline
• DIR Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
• DIR Human Papillomavirus Testing in Head and Neck Carcinomas
• DIR Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline
• DIR Impact of the implementation of a population-based cervical cancer screening program based on European recommendations (test/interval) with regard to the current situation
• DIR Improving outcomes for people with brain and other central nervous system tumours (CSG10)
• DIR Improving outcomes for people with sarcoma (CSG9)
• DIR Improving outcomes in children and young people with cancer (CSG7)
• DIR Improving outcomes in urological cancers (CSG2)
• DIR Improving supportive and palliative care for adults with cancer (CSG4)
• DIR Inibidores de tirosina quinase — Câncer de pulmão não pequenas células com translocação de ALK, localmente avançado ou metastático, em segunda linha de tratamento
• DIR Initial Management of Non-Castrate Advanced, Recurrent or Metastatic Prostate Cancer
• DIR Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update
• DIR Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First Line Chemotherapy 7-13v2
• DIR Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update
• DIR INTERVAL CANCERS IN THE EARLY BREAST CANCER DETECTION PROGRAMME
• DIR Interventions to Address Sexual Problems in People with Cancer 19-6
• DIR Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline
• DIR Invasive Mediastinal Staging of Non-small Cell Lung Cancer 17-6V2
• DIR Ipilimumabe + nivolumabe — Primeira linha de câncer de células renais
• DIR Ipilimumabe — Melanoma metastático com progressão após quimioterapia
• DIR Ixequizumabe — Adultos com espondiloartrite axial com resposta prévia inadequada ou intolerância aos inibidores do fator de necrose tumoral
• DIR Laringe eletrônica — Neoplasia maligna da laringe
• DIR Larotrectinibe — Pacientes pediátricos com tumores sólidos localmente avançados ou metastáticos positivos para fusão do gene NTRK
• DIR Larotrectinibe — Tumores sólidos localmente avançados ou metastáticos positivos para fusão do gene NTRK
• DIR Lenvatinibe — Carcinoma diferenciado da tireoide localmente avançado e/ou metastático, refratário ao iodo, progressivo
• DIR Leptomeningeal metastases
• DIR Linfadenectomia seletiva guiada — Oncologia
• DIR Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
• DIR Long term follow up of survivors of childhood cancer (SIGN CPG 132)
• DIR Lorlatinibe — Câncer de pulmão não pequenas células com translocação em ALK em estágio localmente avançado ou metastático como primeira linha de tratamento
• DIR Lung cancer: diagnosis and management
• DIR Lung cancer in adults
• DIR Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline
• DIR Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline
• DIR Management of adult testicular germ cell tumours (SIGN CPG 124)
• DIR Management of Cancer Cachexia: ASCO Guideline
• DIR Management of Cancer Cachexia: Rapid Update
• DIR Management of Cancer Pain
• DIR Management of Cervical Cancer (Second Edition)
• DIR Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
• DIR Management of Dyspnea in Advanced Cancer: ASCO Guideline
• DIR Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
• DIR Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
• DIR Management of lung cancer (SIGN CPG 137)
• DIR Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
• DIR Management of Nasopharyngeal Carcinoma
• DIR Management of pancreatic cancer: capita selecta
• DIR Management of primary cutaneous squamous cell carcinoma (SIGN CPG 140)
• DIR Management of Salivary Gland Malignancy: ASCO Guideline
• DIR Management of Squamous Cell Cancer of the Anal Canal 2-8v2
• DIR Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and the American Society of Clinical Oncology Joint Guideline 1-23-A
• DIR Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline
• DIR Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: American Society of Clinical Oncology Endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology Consensus Guideline
• DIR Mesilato de imatinibe — Quimioterapia adjuvante do tumor do estroma gastrointestinal
• DIR Metastatic malignant disease of unknown primary origin in adults: diagnosis and management
• DIR Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update
• DIR Metastatic spinal cord compression in adults: risk assessment, diagnosis and management (CG75)
• DIR Models of Care for Cancer Survivorship 26-1v2
• DIR Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
• DIR Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline
• DIR Molecular Testing for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the CAP/IASLC/AMP Guideline
• DIR Monitorização Intraoperatória Neurofisiológica — Pacientes com tumor cerebelopontino submetidos à cirurgia de exérese tumoral com alto risco de sequelas neurológicas
• DIR Musculoskeletal Tumor Society Clinical Practice Guideline on the Management of Metastatic Humeral Disease
• DIR National practice guideline on the treatment of localised prostate cancer – part 2
• DIR Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma 4-1v2
• DIR Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer
• DIR Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
• DIR Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
• DIR Niraparibe — Manutenção de pacientes adultas com carcinoma de ovário (incluindo trompa de Falópio ou peritoneal primário), de alto grau (grau 2 ou maior), avançado (estágio FIGO III ou IV), com mutação nos genes BRCA 1/2, que respondem à quimioterapia em
• DIR Nivolumabe — Adultos com câncer de estômago ou da junção esofagogástrica, avançado ou metastático não tratados anteriormente
• DIR Nivolumabe — Adultos com carcinoma espinocelular de cabeça e pescoço recidivado ou metastático após quimioterapia à base de platina (i.e., segunda linha de tratamento da doença recidivado ou metastática).
• DIR Nivolumabe — Segunda linha para pacientes com carcinoma de células renais metastático
• DIR Nivolumabe — Tratamento adjuvante de pacientes adultos com diagnóstico confirmado de carcinoma de esôfago após tratamento trimodal (quimioterapia, radioterapia e cirurgia)
• DIR Nivolumabe e o pembrolizumabe — Primeira linha do carcinoma de esôfago avançado ou metastático em pacientes com maior expressão de PD-L1
• DIR Non-pharmacological interventions for cancer-related fatigue in men treated for prostate cancer (Best Practice 16(12))
• DIR Non-Small Cell and Small Cell Lung Cancer: Diagnosis, Treatment and Follow-up
• DIR Oesophago-gastric cancer
• DIR Oesophago-gastric cancer: assessment and management in adults
• DIR Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline
• DIR Oral cavity cancer: diagnosis, treatment and follow-up
• DIR Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update
• DIR Palbociclibe — Adultas com câncer de mama avançado ou metastático com HR+ e HER2-
• DIR Palliative care requirements in the case of non-oncological diseases. A qualitative study from the perspective of professionals, patients and carers
• DIR Pancreatic cancer
• DIR Pancreatic cancer in adults: diagnosis and management
• DIR Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline
• DIR Patient safety issues: key components of chemotherapy labelling 12-11v2
• DIR PD-L1 and TMB Testing of Patients with Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies
• DIR Pembrolizumabe + axitinibe — Primeira linha de câncer de células renais
• DIR Pembrolizumabe — Câncer de pulmão não pequenas células avançado ou metastático
• DIR Pembrolizumabe — Carcinoma espinocelular de cabeça e pescoço recidivado ou metastático
• DIR Pembrolizumabe em primeira linha — Câncer de cólon e reto metastático e alta instabilidade de microssatélite
• DIR Pertuzumabe — Câncer de mama HER2-positivo metastático em primeira linha de tratamento associado ao trastuzumabe e docetaxel
• DIR Pertuzumabe em combinação com trastuzumabe e quimioterapia — Tratamento neoadjuvante de pacientes com câncer de mama HER2-positivo inicial
• DIR Pertuzumabe e trastuzumabe em dose fixa subcutânea — Metastático de pacientes com câncer de mama HER2-positivo em primeira linha
• DIR PET-CT — Detecção de metástase de câncer colorretal, exclusivamente hepática e potencialmente ressecável
• DIR PET-CT — Estadiamento de pacientes com doença localmente avançada de carcinoma de esôfago não sabidamente metastático (após resultados inconclusivos na TC)
• DIR PET Imaging in Anal Canal Cancer 17
• DIR PET Imaging in Brain Cancer 10
• DIR PET Imaging in Cervical Cancer 6
• DIR PET Imaging in Esophageal Cancer 4v2
• DIR PET Imaging in Pancreatic Cancer 5
• DIR PET Imaging in Small Cell Lung Cancer 9
• DIR PET Imaging in Testicular Cancer 8
• DIR Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
• DIR Postoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline
• DIR Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy
• DIR Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
• DIR Preoperative or Postoperative Therapy for Resectable Esophageal Cancer 2-11v4
• DIR Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
• DIR Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline
• DIR Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-based Chemotherapy and Radiation 4-5
• DIR Procedimento - Quimioterapia Adjuvante — Carcinoma Epidermoide de cabeça e pescoço
• DIR Procedimentos de hormonioterapia adjuvante à radioterapia externa — Câncer de próstata
• DIR Procedimentos de hormonioterapia prévia à radioterapia externa — Câncer de próstata
• DIR Prostate cancer
• DIR Prostate cancer: diagnosis and management
• DIR Prostate Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement
• DIR Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline
• DIR Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline
• DIR Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline
• DIR Ramucirumabe — Adultos diagnosticados com câncer de estômago ou junção gastroesofágica avançado ou metastático refratários à primeira linha de tratamento
• DIR Rastreamento do Câncer do Colo do Útero (Diretriz Brasileira)
• DIR Recommandations concernant le dépistage du cancer du sein chez les femmes de 40 à 74 ans qui ne sont pas à risque accru de cancer du sein
• DIR Recommandations sur le dépistage du cancer du poumon
• DIR Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
• DIR Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update
• DIR Recommendations on screening for cervical cancer
• DIR Referral of Suspected Prostate Cancer by Family Physicians and Other Primary Care Providers 24-3v2
• DIR Regorafenibe — Tumor do estroma gastrointestinal avançado ou metastático, após falha ao imatinibe e sunitinibe
• DIR Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma 2-33v2
• DIR Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update
• DIR Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline
• DIR Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion
• DIR RT-PCR — Identificação de mutação do receptor do fator de crescimento epidérmico (EGFR) em pacientes com câncer de pulmão de células não pequenas
• DIR Safe Administration of Chemotherapy: Methods and Development 12-12M
• DIR Safe administration of systemic cancer therapy.Part 2: Administration of chemotherapy and management of preventable adverse event. 12-12-2v2
• DIR Safe Administration of Systemic Cancer Therapy Part 1: Safety During Chemotherapy Ordering, Transcribing, Dispensing, and Patient Identification 12-12-1
• DIR Salivary Gland Hypofunction and/or Xerostomia Induced by Non-Surgical Cancer Therapies
• DIR Sarcoma
• DIR Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation
• DIR Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer: An American Society of Clinical Oncology Clinical Practice Guideline Adaptation
• DIR Sebaceous Carcinoma: Evidence-Based Clinical Practice Guidelines
• DIR Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion
• DIR Secondary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline
• DIR Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Rapid Update
• DIR Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
• DIR Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update
• DIR Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
• DIR Sentinel Lymph Node Biopsy in Vulvar Cancer 4-17v2
• DIR Sequenciamento de Nova Geração — Identificação de mutação nos genes BRCA1/2 em mulheres com câncer
• DIR Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
• DIR Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse event
• DIR Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer
• DIR Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer
• DIR Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
• DIR Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
• DIR Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma
• DIR Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
• DIR Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ
• DIR Sorafenibe — Carcinoma diferenciado da tireoide localmente avançado e/ou metastático, refratário ao iodo, progressivo
• DIR Spinal metastases and metastatic spinal cord compression
• DIR Spinal metastases and metastatic spinal cord compression
• DIR Staging and Surgical Approaches in Gastric Cancer 2-19
• DIR Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline
• DIR Succinato de ribociclibe — Adultas com câncer de mama avançado ou metastático com HR+ e HER2-
• DIR Sunitinibe — Indivíduos com tumor do estroma gastrointestinal avançado ou metastático, após falha ao imatinibe e sunitinibe
• DIR Sunitinibe ou pazopanibe — Portadores de carcinoma renal de células claras metastático
• DIR Supportive treatment for cancer - Part 2: Prevention and treatment of adverse events related to chemotherapy and radiotherapy
• DIR Supportive treatment for cancer – Part 3: Treatment of pain: most common practices
• DIR Surgical, Radiation, and Systemic Treatments of Patients with Thymic Epithelial Tumours 7-11v3
• DIR Suspected cancer: recognition and referral
• DIR Systematic Review and Evidence-Based Guidelines Update for the Role of Emerging Therapies in the Management of Patients with Metastatic Brain Tumors
• DIR Systemic Therapy for Advanced Gastric and Gastro-Esophageal Carcinoma 2-26 v3
• DIR Systemic therapy for advanced or recurrent endometrial cancer, and advanced or recurrent uterine papillary serous carcinoma 4-8v4
• DIR Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer
• DIR Systemic therapy for recurrent, metastatic, or persistent cervical cancer 4-20v2
• DIR Systemic therapy for unresectable advanced or metastatic pancreatic and midgut neuroendocrine tumours: Version 2 2-21v2
• DIR Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer (CRPC) Guideline and Rapid Update
• DIR Systemic therapy in men with metastatic castration-resistant prostate cancer 3-15v2
• DIR Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline
• DIR Systemic Treatment for Patients with Advanced Non-Small Cell Lung Cancer 7-22
• DIR Testagem Molecular — Detecção de HPV e rastreamento do câncer do colo do útero
• DIR The decisional process for the choice of active surveillance in localized prostate cancer
• DIR The effectiveness and safety of different forms of treating prostate cancer
• DIR The Management of Depression in Patients with Cancer 19-4v2
• DIR The prevention and treatment of oral mucositis in cancer patients (Best Practice 2(3))
• DIR Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO Guideline
• DIR Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update 7-A-2018-3
• DIR Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
• DIR Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
• DIR Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations
• DIR Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations
• DIR The Role of Endolaryngeal Surgery (With or Without Laser) versus Radiotherapy in the Management of Early (T1) Glottic Cancer 5-2v2
• DIR The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement 2-31
• DIR The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
• DIR The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
• DIR The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
• DIR The Treatment of Metastatic Carcinoma and Myeloma of the Femur: Clinical Practice Guideline
• DIR The use of systemic treatment in the maintenance of patients with non-small cell lung cancer
• DIR The use of targeted therapies in patients with inoperable locally advanced or metastatic renal cell cancer 3-8-4v2
• DIR The Utility of PET/CT in Colorectal Cancer Metastasis: An Evidence Summary 15
• DIR Tomografia computadorizada por emissão de pósitrons — Pacientes com câncer de pulmão de células pequenas
• DIR Tomografia por Emissão de Pósitrons (PET-CT) — Câncer de mama metastático (quando os exames de imagem convencionais apresentarem achados equívocos)
• DIR Trastuzumabe — Adultos com câncer de estômago ou da junção esofagogástrica, avançado ou metastático, HER2+ e não tratados anteriormente (1ª linha)
• DIR Trastuzumabe entansina em monoterapia — Tratamento de pacientes com câncer de mama HER2-positivo metastático ou localmente avançado iressecável, com tratamento prévio de trastuzumabe e um taxano
• DIR Treatment for Brain Metastases: ASCO Guideline
• DIR Treatment of Locally Advanced Esophageal Carcinoma
• DIR Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline
• DIR Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline
• DIR Treatment of Metastatic Colorectal Cancer: ASCO Guideline
• DIR Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline
• DIR Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline
• DIR Tumor Cerebral no Adulto (DDT)
• DIR Tumour markers in certain cancer locations
• DIR Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
• DIR Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline
• DIR Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline—Integration of Results From TAILORx
• DIR Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
• DIR Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
• DIR Vismodegibe — Carcinoma basocelular localmente avançado ou metastático sem indicação de cirurgia e radioterapia
• DIR Vulvar neoplasms
• DIR WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
• DIR WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
• DIR WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
• DIR WHO guideline on preventive chemotherapy for public health control of strongyloidiasis

Documentos para Download:

• PDF Luxação aguda da patela
• PDF Fratura do colo do tálus
• DIR 2022 Saudi Guideline for Low Back Pain
• DIR AAOS/AAHKS The Prevention of Total Hip and Knee Arthroplasty Periprosthetic Joint Infection in Patients Undergoing Dental Procedures
• DIR AAOS/ASSH Management of Distal Radius Fractures Evidence-Based Clinical Practice Guideline
• DIR AAOS Appropriate Use Criteria: Hip Fractures in Older Adults: Acute Treatment
• DIR AAOS Appropriate Use Criteria: Humeral Component Design During Primary Anatomic Total Shoulder Arthroplasty
• DIR AAOS Appropriate Use Criteria: Postoperative Rehabilitation of Low Energy Hip Fractures in Older Adults
• DIR AAOS Appropriate Use Criteria: Prevention of Secondary Hip Fracture and/or Fragility Fracture
• DIR AAOS Appropriate Use Criteria: Treatment for Shoulder OA with Intact Rotator Cuff and Severe Glenoid Retroversion
• DIR AAOS Appropriate Use Criteria for Management of Developmental Dysplasia of the Hip in Infants up to Six Months of Age: Intended for Use by Orthopaedic Specialists
• DIR AAOS Appropriate Use Criteria for Pharmacologic, Physical, and Cognitive Pain Alleviation for Musculoskeletal Extremity/Pelvis Surgery
• DIR AAOS Appropriate Use Criteria for Shoulder OA with Intact Rotator Cuff and Severe Glenoid Retroversion
• DIR AAOS Appropriate Use Criteria for the Management of Osteoarthritis of the Hip
• DIR AAOS Appropriate Use Criteria for the Management of Osteoarthritis of the Knee (Non-Arthroplasty)
• DIR AAOS Appropriate Use Criteria for the Management of Pediatric Supracondylar Humerus Fractures
• DIR AAOS Appropriate Use Criteria for the Management of Pediatric Supracondylar Humerus Fractures with Vascular Injury
• DIR AAOS Appropriate Use Criteria for the Surgical Management of Osteoarthritis of the Knee
• DIR AAOS Appropriate Use Criteria for the Treatment of Distal Radius Fractures (2021)
• DIR AAOS Appropriate Use Criteria for Treatment of Distal Radius Fractures
• DIR AAOS Clinical Practice Guideline for Pharmacologic, Physical, and Cognitive Pain Alleviation for Musculoskeletal Extremity/Pelvis Surgery
• DIR AAOS Clinical Practice Guideline for the Management of Hip Fractures in Older Adults
• DIR AAOS Clinical Practice Guideline for the Management of Osteoarthritis of the Knee (Non-Arthroplasty) (3rd Edition)
• DIR AAOS Clinical Practice Guideline on the Management of Osteoarthritis of the Hip
• DIR AAOS Evidence-Based Clinical Practice Guideline for the Surgical Management of Osteoarthritis of the Knee
• DIR AAOS Evidence-Based Clinical Practice Guideline for the Treatment of Clavicle Fractures
• DIR AAOS Evidence-Based Clinical Practice Guideline on Treatment of Distal Radius Fracture
• DIR AAOS Evidence-Based Clinical Practice Guideline on Treatment of Pediatric Diaphyseal Femur Fractures
• DIR AAOS Evidence-Based Clinical Practice Guideline on Treatment of Pediatric Supracondylar Humerus Fractures
• DIR AAOS Management of Glenohumeral Joint Osteoarthritis Evidence-Based Clinical Practice Guideline
• DIR Analysis of the scientific evidence on the effectiveness and efficiency of different kinds of hip prosthesis. Recomendations
• DIR Arthroscopy with joint washout in the treatment of knee arthrosis
• DIR Clinical Practice Guideline for Psychological and Other Nonpharmacological Treatment of Chronic Musculoskeletal Pain in Adults
• DIR Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Perioperative Spine: Preoperative Opioid Evaluation
• DIR Congress of Neurological Surgeons Systematic Review and Evidence-based Guidelines for Perioperative Spine: Preoperative Surgical Risk Assessment
• DIR Diretrizes Brasileiras — Fratura do colo do fêmur no idoso
• DIR Fractures (complex): assessment and management
• DIR Fractures (non-complex): assessment and management
• DIR Fratura do Colo do Fêmur em Idosos (Linha de Cuidado)
• DIR Fratura do Colo do Fêmur em Idosos - Tratamento - Diretrizes Brasileiras
• DIR Guideline for the management of knee and hip osteoarthritis, second edition
• DIR Guideline for the management of knee and hip osteoarthritis. Second edition
• DIR Hastes telescópicas — Correção de deformidades e prevenção de fraturas em crianças e adolescentes em fase de crescimento com osteogênese imperfeita
• DIR Hilano G-F 20 — Intra-articular no tratamento de dor associada com a osteoartrose do joelho
• DIR Hip fracture: management
• DIR Hip fracture in adults
• DIR International Clinical Practice Guideline for the Conservative Management of Chronic Musculoskeletal Neck Pain
• DIR Intra-articular injection of platelet-rich plasma for treating knee arthrosis
• DIR Joint replacement (primary): hip, knee and shoulder
• DIR Joint replacement (primary): hip, knee and shoulder
• DIR Knee and hip osteoarthritis
• DIR KNGF Guideline for Physical Therapy in patients with Low Back Pain
• DIR KNGF Guideline for Physical Therapy in patients with osteoarthritis of the hip and knee
• DIR Korean Medicine Clinical Practice Guideline for Shoulder Pain
• DIR Low back pain and radicular pain: evaluation and management
• DIR Low back pain and sciatica in over 16s
• DIR Low back pain and sciatica in over 16s: assessment and management
• DIR Management of acute deltoid ligament inury in ankle fracture
• DIR Management of Mandibular Condyle Fracture (Second Edition)
• DIR Management of Osteoarthritis (Second Edition)
• DIR MODELS OF LOWER BACK PAIN: RELIABILITY OF A CLASSIFICATION MODEL
• DIR Naproxeno — Osteoartrite de joelho e quadril (ampliação de uso)
• DIR Non-Pharmacological and Pharmacological Management of Acute Pain from Non-Low Back, Musculoskeletal Injuries in Adults: A Clinical Guideline from the American College of Physicians and American Academy of Family Physicians
• DIR Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
• DIR Orthotic Management of Adolescent Idiopathic Scoliosis
• DIR Osteoarthritis in over 16s
• DIR Osteoarthritis in over 16s: diagnosis and management
• DIR Pain in the back – Avoiding back pain in children and teenagers Attached the guideline
• DIR Physical Therapist Management of Total Knee Arthroplasty
• DIR Recommandations sur le dépistage pour la prévention primaire des fractures de fragilisation
• DIR Romosozumabe — Mulheres com osteoporose na pós menopausa, a partir de 70 anos, que apresentam risco muito alto de fratura por fragilidade e que falharam (apresentaram duas ou mais fraturas) com o padrão de tratamento medicamentoso.
• DIR Sysadoas. Chondroprotective drugs in the treatment of arthritis
• DIR The health, economic and social impact of low back pain in the Autonomous Community of the Basque Country
• DIR The management of acute/subacute soft tissue injuries to the low back: evidence update and recommendations for clinical practice
• DIR The Management of Low Back Pain in Adults
• DIR The prevention and management of shoulder pain in the hemiplegic patient (Best Practice 7(4))
• DIR Use of radiography in diagnosing low back pain: systematic review
• DIR When to order MRI for low back pain
• DIR WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings
• DIR WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings

Documentos para Download:

• DIR Cadeira de rodas motorizada — Incapacidade de deambulação, ausência de controle de tronco, cognição, audição e visão suficientemente preservados
• DIR Clinical Practice Guideline: Acute Otitis Externa
• DIR Clinical Practice Guideline: Adult Sinusitis (Update)
• DIR Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update)
• DIR Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations
• DIR Clinical Practice Guideline: Otitis Media with Effusion (Update)
• DIR Clinical Practice Guideline: Sudden Hearing Loss (Update)
• DIR Clinical Practice Guideline: Tinnitus
• DIR Clinical Practice Guideline: Tonsillectomy in Children (Update)
• DIR Cost-effectiveness analysis of treatments of the Sleep Apnea Syndrome in the Basque Country
• DIR Diagnosis of Obstructive Sleep Apnea in Adults: A Clinical Practice Guideline From the American College of Physicians
• DIR Hearing loss in adults
• DIR Hearing loss in adults: assessment and management
• DIR Interventions to improve CPAP treatment adherence in patients with obstructive sleep apnea
• DIR Management of Obstructive Sleep Apnea in Adults: A Clinical Practice Guideline From the American College of Physicians
• DIR Management of Otitis Media with Effusion in Children
• DIR Otitis media with effusion in under 12s
• DIR Otitis media with effusion in under 12s: surgery (CG60)
• DIR Radiofrequency tonsil reduction
• DIR Systematic Review and Evidence-Based Guideline on Hearing Preservation Outcomes in Patients with Sporadic Vestibular Schwannoma: Update
• DIR Tinnitus: assessment and management
• DIR ​Tonsillitis in adults and children

Documentos para Download:

• DIR Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies: Guideline From the College of American Pathologists in Collaboration With the American Association for Clinical Chemistry and the American Society for Clinical Pathology
• DIR Laboratory testing for dengue virus
• DIR Laboratory test requests - Part 1
• DIR Laboratory Workup of Amyloidosis
• DIR To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis
• DIR WHO guidelines for plague management

Documentos para Download:

• PDF Síndrome de Prader Willi e tratamento com Somatropina
• DIR AAOS Appropriate Use Criteria for the Management of Developmental Dysplasia of the Hip in Infants up to Six Months of Age: Intended for Use by General Pediatricians and Referring Physicians
• DIR AAOS Appropriate Use Criteria Pediatric Developmental Dysplasia of the Hip in Infants up to Six Months of Age: General Pediatricians and Referring Physicians
• DIR ​Acute diarrhoea in children
• DIR Antisocial behaviour and conduct disorders in children and young people
• DIR Antisocial behaviour and conduct disorders in children and young people: recognition and management
• DIR Asia-Pacific Guidelines for Long-Acting Growth Hormone Therapy
• DIR ASSESSMENT & MANAGEMENT OF ACUTE DIARRHOEA IN CHILDREN
• DIR Babies, children and young people's experience of healthcare
• DIR Bedwetting in children and young people
• DIR Burosumabe — Hipofosfatemia ligada ao cromossomo X em crianças
• DIR Cadeira de rodas para banho em concha infantil — Desenvolvimento e aprimoramento de tecnologias assistivas e meios auxiliares de locomoção
• DIR Carbohydrate intake for adults and children
• DIR Cerebral palsy in children and young people
• DIR Childhood Immunisation
• DIR Child maltreatment: when to suspect maltreatment in under 18s
• DIR Children's attachment
• DIR Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care
• DIR Children’s experiences of postoperative pain management (Best Practice 17(7))
• DIR Claritromicina comprimido — Hanseníase em adultos e crianças com reação adversa ao tratamento de primeira linha
• DIR Claritromicina granulado — Suspensão oral esquema de segunda linha para hanseníase em adultos e crianças com reação adversa ao tratamento de primeira linha
• DIR Clinical Practice Guideline: Tympanostomy Tubes in Children (Update)
• DIR Clinical practice guideline on care in normal childbirth
• DIR Clinical Practice Guideline on major depression in childhood and adolescence. Update.
• DIR Cloridrato de Propranolol (solução oral 3,75 mg/mL) — Hemangiona Infantil
• DIR Constipation in children and young people
• DIR Constipation in children and young people: diagnosis and management
• DIR Dental interventions to prevent caries in children (SIGN CPG 138)
• DIR Developmental follow-up of children and young people born preterm
• DIR Developmental follow-up of children and young people born preterm
• DIR Diagnosis and Management of the Common Cold in Adults and Children
• DIR Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education
• DIR Doses Fixas Pediátricas RHZ (Rifampicina 75 mg + Isoniazida 50 mg + Pirazinamida 150 mg) e RH (Rifampicina 75 mg + Isoniazida 50 mg) comprimidos dispersíveis — Tuberculose em crianças menores de 10 anos
• DIR Early years: promoting health and wellbeing in under 5s
• DIR Effectiveness of non-pharmacological pain management in relieving chronic pain for children and adolescents (Best Practice 14(17))
• DIR End of life care for infants, children and young people
• DIR End of life care for infants, children and young people with life-limiting conditions: planning and management
• DIR ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children
• DIR Espectrometria de massas em tandem (MS/MS) — Triagem neonatal em sangue seco, colhido em papelfiltro, para a doença Homocistinúria Clássica (HCU)
• DIR Estradiol adesivo transdérmico — para indução da puberdade em adolescentes do sexo feminino com hipogonadismo hipogonadotrófico orgânico
• DIR Faltering growth: recognition and management of faltering growth in children
• DIR Fever in under 5s
• DIR Fever in under 5s: assessment and initial management
• DIR Guía de Práctica Clínica sobre Cuidados Paliativos en Pediatría
• DIR Guideline: infant feeding in areas of Zika virus transmission
• DIR Guideline for Growth, Health and Developmental Follow-up for Children Born Very Preterm
• DIR Guideline for Growth, Health and Developmental Follow-up for Children Born Very Preterm from School Age to Adulthood
• DIR Guidelines on the management of chronic pain in children
• DIR Harmful sexual behaviour among children and young people
• DIR Hemangioma Infantil
• DIR Identification of risk circumstances of child maltreatment in families
• DIR Implante subdérmico de etonogestrel — Adolescentes de 14 a 17 anos
• DIR Improving early childhood development
• DIR INTEGRATED INTRA AND EXTRA-HOSPITAL APPROACH TO CONDUCT DISORDERS
• DIR Intravenous fluid therapy in children and young people in hospital
• DIR Intravenous fluid therapy in children and young people in hospital
• DIR Jaundice in newborn babies under 28 days
• DIR Jaundice in newborn babies under 28 days
• DIR Looked-after children and young people
• DIR Looked-after children and young people
• DIR Management of Attention Deficit Hyperactive Disorder in Children and Adolescent
• DIR Management of Avulsed Permanent Anterior Teeth in Children (3nd Edition)
• DIR Management of Dengue Fever in Children
• DIR Management of Neonatal Jaundice (Second Edition)
• DIR Management of Rhinosinusitis in Adolescents & Adults
• DIR Management of Severe Early Childhood Caries (2nd Edition)
• DIR Management of the child with fever (Best Practice 5(5))
• DIR Medical identification and reporting of incest: recognising intrafamilial child sexual abuse
• DIR Migalastate — Adultos e adolescentes de 12 anos ou mais com diagnóstico de doença de Fabry e que possuam uma variante patogênica suscetível
• DIR Non-pharmacological management of fever in otherwise healthy children (Best Practice 16(7))
• DIR Onasemnogeno abeparvoveque — Tratamento de pacientes pediátricos até 6 meses de idade com Atrofia Muscular Espinhal (AME) do tipo I que estejam fora de ventilação invasiva acima de 16 horas por dia.
• DIR Parental involvement in their children’s postoperative pain management in hospital (Best Practice 16 (3))
• DIR Policies to protect children from the harmful impact of food marketing
• DIR Positioning of preterm infants for optimal physiological development (Best Practice 14(18))
• DIR Praziquantel — Crianças de 2 a 4 anos de idade com esquistossomose
• DIR PROPOSAL FOR A PROGRAMME FOR THE EARLY DETECTION OF INFANT DEAFNESS IN THE BASQUE AUTONOMOUS COMMUNITY
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Hemangioma Infantil
• DIR Raltegravir — Uso pediátrico
• DIR Ravulizumabe — Pacientes adultos e pediátricos com síndrome hemolítico-urêmica atípica
• DIR RESULTS OF THE PERINATAL CARE OF VERY PREMATURE CHILDREN IN THE HEALTH SERVICE OF THE BASQUE COUNTRY
• DIR Saturated fatty acid and trans-fatty acid intake for adults and children
• DIR Selumetinibe — Pediátricos com neurofibromatose tipo 1 (NF1) e neurofibroma plexiforme inoperável sintomático
• DIR Sistema de frequência modulada pessoal – FM — Equipamento que possibilita a acessibilidade da criança e/ou jovem com deficiência auditiva na escola
• DIR Testosterona injetável — Uso da testosterona injetável em homens e em adolescentes do sexo masculino com hipogonadismo hipogonadotrófico orgânico
• DIR The adolescent health indicators recommended by the Global Action for Measurement of Adolescent health
• DIR The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings (Best Practice 14(8))
• DIR The effectiveness of interventions for infant colic
• DIR The effectiveness of interventions for infant colic (Best Practice 12(6))
• DIR The experience and role of a companion during normal labor and childbirth (Best Practice 18(4))
• DIR The impact of hospital visiting hour policies on paediatric and adult patients and their visitors (Best Practice 14(14))
• DIR The Use of Growth Hormone in Children and Adults
• DIR Tiamazol — Hipertireoidismo em crianças e adolescentes
• DIR Transition from children's to adults' services
• DIR Transition from children's to adults' services for young people using health or social care services
• DIR Triagem neonatal por espectrometria de massas em tandem (MS/MS) — Detecção da deficiência de acil-CoA desidrogenase de cadeia média (MCADD)
• DIR Weight management: lifestyle services for overweight or obese children and young people (PH47)
• DIR WHO Guideline for complementary feeding of infants and young children 6-23 months of age
• DIR WHO guideline on mass drug administration of azithromycin to children under five years of age to promote child survival
• DIR WHO guidelines on parenting interventions to prevent maltreatment and enhance parent–child relationships with children aged 0–17 years
• DIR WHO recommendations for care of the preterm or low-birth-weight infant
• DIR Witholding & Withdrawing of Life Support in Children
• DIR Working with Families to Promote Safe Sleep for Infants 0-12 Months of Age

Documentos para Download:

• DIR 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the Respiratory Society (ERS)
• DIR Adult Asthma Care: Promoting Control of Asthma
• DIR Alteplase para tratamento da embolia pulmonar aguda — Embolia pulmonar aguda
• DIR ANALYSIS OF THE STATUS, SYSTEMATIC REVIEW AND VALIDATION OF A DIAGNOSTIC ALGORITHM FOR PULMONARY THROMBOEMBOLISM (PTE) IN THE HOSPITAL EMERGENCY SERVICES OF THE BASQUE HEALTH SERVICE
• DIR Asian Consensus on Diagnostic Pathways for Invasive Pulmonary Fungal Diseases in High-burden Countries
• DIR Asma
• DIR Asthma
• DIR Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)
• DIR Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) (NG245)
• DIR ​Asthma in adults
• DIR ​Asthma in children
• DIR Asthma optimising long-term management with inhaled corticosteroid
• DIR Asthma pathway (BTS, NICE, SIGN)
• DIR Asthma pathway (BTS, NICE, SIGN) (NG244)
• DIR Australasian Bronchiolitis Guideline: 2023 Update
• DIR Australian Living Guidelines for the Management of Respiratory Distress Syndrome (RDS)
• DIR Beclometasona — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Benralizumabe — Adjuvante de manutenção para asma grave com fenótipo eosinofílico em pacientes adultos
• DIR Benralizumabe — Asma eosinofílica grave refratária em pacientes com idade de 18 anos ou mais
• DIR British guideline on the management of asthma (SIGN CPG 158)
• DIR Brometo de tiotrópio — Doença pulmonar obstrutiva crônica
• DIR Brometo de tiotrópio monoidratado + cloridrato de olodaterol — Doença pulmonar obstrutiva crônica graves e muito graves (estágio 3 e 4), com alto risco (C e D) e demais critérios definidos no Protocolo Clínico e Diretrizes Terapêuticas do Ministério da Sa
• DIR Brometo de umeclidínio + trifenatato de vilanterol — Doença pulmonar obstrutiva crônica.
• DIR Bronchiolitis in children
• DIR Bronchiolitis in children: diagnosis and management
• DIR Budesonida — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Budesonida 200mcg/formoterol 6mcg em suspensão aerossol — Asma
• DIR Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing
• DIR Chronic Obstructive Pulmonary Disease (COPD) Guideline
• DIR Chronic obstructive pulmonary disease diagnosis and management
• DIR ​Chronic obstructive pulmonary disease in adults
• DIR Chronic obstructive pulmonary disease in adults
• DIR Chronic obstructive pulmonary disease in over 16s: diagnosis and management
• DIR Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
• DIR Clinical Practice Guideline on childhood asthma
• DIR Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Perioperative Spine: Preoperative Pulmonary Evaluation and Optimization
• DIR Cost-effectiveness analysis of a telemonitoring experiment in patients with cardiac insufficiency and chronic obstructive pulmonary disease
• DIR Costs-impact analysis of a telemedicine procedure in spirometry quality assurance programs in patients with COPD
• DIR DESCRIPTION OF THE ELABORATION OF A CLINICAL PRACTICE GUIDELINE FOR ASTHMA IN THE AUTONOMOUS COMMUNITY OF THE BASQUE COUNTRY BY MEANS OF A MIXED METHOD OF ADAPTATION-DEVELOPMENT-ACTUALIZATION
• DIR Diagnosis and Management of Asthma in Adults
• DIR Diagnosis and Management of Asthma in Children
• DIR Dipropionato de beclometasona 100 µg fumarato de formoterol di-hidratado 6 µg e brometo de glicopirrônio 12,5 µg no tratamento da DPOC grave (30% ≤ VEF1 < 50%) e muito grave (VEF1 < 30%) grupo C e grupo D — Pulmonar obstrutiva crônica grave e muito grave
• DIR Doença Pulmonar Obstrutiva Crônica
• DIR Esilato de nintedanibe — Fibrose pulmonar idiopática
• DIR Evaluation of bubble humidification systems in low-flow oxygen therapy. Systematic review and cost analysis
• DIR Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians
• DIR Everolimo — Transplantes pulmonares
• DIR Exames diagnósticos — Deficiência de alfa-1 antitripsina para portadores de DPOC
• DIR Fenoterol — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Fluticasona — Asma
• DIR Fluticasona — Doença pulmonar obstrutiva crônica
• DIR Fluticasona — Redução dos sintomas e exacerbações da asma em pacientes tratados com broncodilatadores isolados ou outra terapia profilática
• DIR Formoterol — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Furoato de fluticasona/brometo de umeclidínio/trifenatato — Doença Pulmonar Obstrutiva Crônica (DPOC) grave a muito grave (GOLD 3 e 4) com perfil exacerbador e sintomático (Grupo D)
• DIR Idiopathic pulmonary fibrosis in adults
• DIR Idiopathic pulmonary fibrosis in adults: diagnosis and management
• DIR Implante de válvulas endobronquiais unidirecionais — Enfisema pulmonar heterogêneo
• DIR Indacaterol — Doença pulmonar obstrutiva crônica
• DIR KNGF Guideline for Physical Therapy in patients with Chronic Obstructive Pulmonary Disease (COPD)
• DIR Management of Asthma in Adults
• DIR Management of Chronic Obstructive Pulmonary Disease (Second Edition)
• DIR Management of Pulmonary Aterial Hypertension (PAH)
• DIR Measurement of the fraction of exhaled nitric oxide in the diagnosis and treatment of asthmatic children
• DIR Mepolizumabe — Asma eosinofílica grave refratária em pacientes com idade de 18 anos ou mais
• DIR Mepolizumabe — Asma eosinofílica grave refratária entre 6 e 17 anos de idade
• DIR Nirsevimabe — Prevenção de infecção do trato respiratório inferior associado ao vírus sincicial respiratório para os bebês prematuros menores que 37 semanas e crianças menores de 2 anos portadores de comorbidades.
• DIR Nirsevimabe para Prevenção de Infecção do Trato Respiratório Inferior Associado ao Vírus Sincicial Respiratório para Bebês Prematuros ou com Comorbidades (Protocolo de Uso)
• DIR Nursing Care of Dyspnea:The 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease
• DIR Omalizumabe — Asma grave
• DIR Oxigenação Extracorpórea (ECMO) — Suporte de Pacientes com Insuficiência Respiratória Grave e Refratária
• DIR Oxigenação por membrana extracorpórea — Suporte de pacientes com insuficiência respiratória grave
• DIR Oxigenoterapia domiciliar — Portadores de DPOC
• DIR Pirfenidona — Fibrose pulmonar idiopática
• DIR Promoting Asthma Control in Children
• DIR Propionato de fluticasona + xinafoato de salmeterol — Asma em pacientes a partir de 4 anos
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Asma
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Asma
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Asma
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Doença Pulmonar Obstrutiva
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Doença Pulmonar Obstrutiva Crônica
• DIR Protocolo de Uso — Nirsevimabe para Prevenção de Infecção do Trato Respiratório Inferior Associado ao Vírus Sincicial Respiratório para Bebês Prematuros ou com Comorbidades
• DIR Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Adaptation from the American Thoracic Society Clinical Practice Guideline.
• DIR Roflumilaste — Doença obstrutiva crônica (DPOC)
• DIR Salbutamol — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Salmeterol — Medicamentos para tratamento da doença pulmonar obstrutiva crônica (DPOC)
• DIR Sirolimo — Transplantes pulmonares
• DIR Specialist neonatal respiratory care for babies born preterm
• DIR Specialist neonatal respiratory care for babies born preterm
• DIR Spray de Formoterol + Budesonida — Asma
• DIR Support for Older People with COPD in Community Settings (Best Practice 17(4))
• DIR Tacrolimo — Transplantes pulmonares
• DIR The application of GRADE in the development of a CPG on childhood asthma
• DIR The use of inhalation chambers in the treatment of infantile asthma
• DIR Tiotrópio — Asma Moderada e grave em pacientes adultos e crianças (com idade de 6 anos ou mais)
• DIR Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
• DIR Vacina vírus sincicial respiratório (VSR) A e B (recombinante) — Prevenção da doença do trato respiratório inferior causada pelo vírus sincicial respiratório (VSR) em crianças até os 6 meses de idade
• DIR Xinafoato de Salmeterol aerossol bucal 50 mcg — Asma e da Doença Pulmonar Obstrutiva Crônica

Documentos para Download:

• PDF Eletroconvulsoterapia
• PDF Abuso e Dependência da Cocaína
• DIR AAOS Appropriate Use Criteria for the Early Screening for Psychosocial Risk and Protective Factors
• DIR ALTERNATIVES TO SHORT STAY PSYCHIATRIC HOSPITALISATION. INTENSIVE AMBULATORY MONITORING PROGRAMMES
• DIR A National Guideline for the Assessment and Diagnosis of Autism Spectrum Disorders in Australia
• DIR AN EVALUATION OF THE EFFICACY OF PSYCHOSOCIAL TECHNIQUES (COGNITIVE REHABILITATION vs. PSYCHOEDUCATION) AS AN ADDITIONAL TREATMENT TO PHARMACOLOGICAL TREATMENT IN BIPOLAR DISORDER
• DIR Anxiety disorders
• DIR APPROACH TO PERSONALITY DISORDERS IN THE MENTAL HEALTH SYSTEM OF THE BASQUE COUNTRY
• DIR Assessment, diagnosis, care and support for people with dementia and their carers (SIGN CPG 168)
• DIR Assessment, diagnosis and interventions for autism spectrum disorders (SIGN CPG 145)
• DIR Assessment and Care of Adults at Risk for Suicidal Ideation and Behaviour
• DIR Assessment and clinical management of self-harm: evidence-based protocol
• DIR Assessment and Interventions for Perinatal Depression, Second Edition
• DIR Assisting caregivers to support people with dementia (Best Practice 14(9))
• DIR Australian Guidelines for the Prevention and Treatment of Acute Stress Disorder, Posttraumatic Stress Disorder and Complex Posttraumatic Stress Disorder
• DIR Australian guidelines on the treatment of acute stress disorder and posttraumatic stress disorder
• DIR Autism
• DIR Autism spectrum disorder in adults: diagnosis and management
• DIR Autism spectrum disorder in under 19s: recognition, referral and diagnosis
• DIR Autism spectrum disorder in under 19s: support and management
• DIR Bipolar disorder, psychosis and schizophrenia in children and young people
• DIR Bipolar disorder: assessment and management
• DIR Bipolar disorder in adults
• DIR Caregiving experiences of families living with persons with schizophrenia (Best Practice 18(6))
• DIR CASE AND CONTROL STUDY: EFFICIENCY OF THE PSYCHOEDUCATIONAL TREATMENT OF THE OVERLOAD EXPERIENCED BY FAMILY MEMBERS OF BIPOLAR PATIENTS
• DIR Clinical Practice Guideline for the Appropriate Use of Methylenedioxymethamphetamine (MDMA)-assisted Psychotherapy for Post-traumatic Stress Disorder
• DIR Clinical Practice Guideline for the Appropriate Use of Psilocybin-assisted Psychotherapy for Depression
• DIR Clinical practice guideline for the prevention and treatment of suicidal behaviour
• DIR Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts
• DIR Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults
• DIR Clinical practice guideline on the management of depression in adults.
• DIR Clozapina — Transtorno Afetivo Bipolar
• DIR Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings
• DIR Coexisting severe mental illness and substance misuse
• DIR Coexisting severe mental illness and substance misuse: community health and social care services
• DIR Common mental health problems: identification and pathways to care (CG123)
• DIR Complex interactive factors which determine carers' experiences of seeking help for relatives with first- episode psychosis (Best Practice 18(10))
• DIR Comportamento Agressivo no Transtorno do Espectro do Autismo
• DIR Delirium, Dementia, and Depression in Older Adults: Assessment and Care
• DIR Dementia
• DIR Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset
• DIR Dementia: assessment, management and support for people living with dementia and their carers
• DIR Dementia: which non-pharmacological interventions ?
• DIR Depression in adolescents and young adults
• DIR Depression in adults
• DIR Depression in adults: treatment and management
• DIR Depression in adults with a chronic physical health problem: recognition and management
• DIR Depression in children and young people
• DIR Depression in children and young people: identification and management
• DIR Diagnosis and Management of Autism Spectrum Disorder
• DIR Diagnosis and Management of Generalized Anxiety Disorder in Adults
• DIR Drug misuse in over 16s: opioid detoxification
• DIR Drug misuse in over 16s: psychosocial interventions
• DIR Eating disorders
• DIR Eating disorders (SIGN CPG 146)
• DIR Eating disorders: recognition and treatment
• DIR Educational interventions for mental health consumers receiving psychotropic medication (Best Practice 10(4))
• DIR Effectiveness of music listening in reducing depressive symptoms in adults (Best Practice 15(12))
• DIR EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia
• DIR EFNS task force: the use of neuroimaging in the diagnosis of dementia
• DIR Engaging Clients Who Use Substances
• DIR Environmental healthcare design strategies and event related anxiety in pediatric patients (Best Practice 16(11))
• DIR Esquizofrenia
• DIR Evaluation of care quality in the NHS towards severe childhood mental disorders. A study in infant/juvenile mental health services
• DIR Family involvement in decision making for people with dementia in residential aged care (Best Practice 18(2))
• DIR Generalised anxiety disorder – easing burden and enabling remission
• DIR Generalised anxiety disorder and panic disorder in adults: management
• DIR Geographical mental health map: geographical variation in psychosis and association with environmental factors
• DIR Group and individual therapy in the treatment of depression (Best Practice 3(2))
• DIR GROUP MONITORING OF PSYCHOTIC PATIENTS IN THE PUBLIC HEALTH NETWORK OF THE BASQUE AUTONOMOUS COMMUNITY
• DIR Guía de Práctica Clínica de Intervenciones Psicosociales en el Trastorno Mental Grave. Revisión
• DIR Guía de práctica clínica sobre las intervenciones terapéuticas en el Trastorno por Déficit de Atención con Hiperactividad (TDAH)
• DIR Guidelines on mental health promotive and preventive interventions for adolescents
• DIR Interventions to reduce undernutrition and promote eating in older adults with dementia (Best Practice 15(14))
• DIR Lamotrigina — Transtorno Afetivo Bipolar
• DIR Learning disability: identifying and managing mental health problems
• DIR Major depressive disorder – achieving and sustaining remission
• DIR Management of Anxiety and Depression in Adult Survivors of Cancer
• DIR Management of autism in children and young people: a good clinical practice guideline
• DIR Management of Autism Spectrum Disorder in Children and Adolescents
• DIR Management of Bipolar Disorder in Adults
• DIR Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians
• DIR Management of Dementia (2nd edition)
• DIR Management of Major Depressive Disorder (Second Edition)
• DIR Management of schizophrenia (SIGN CPG 131)
• DIR Management of Schizophrenia in Adults
• DIR Mental health care in the perinatal period: Australian clinical practice guideline
• DIR Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders
• DIR Mental health of adults in contact with the criminal justice system
• DIR Mental health of adults in contact with the criminal justice system
• DIR Mental health problems in people with learning disabilities: prevention, assessment and management
• DIR METRC/AAOS Clinical Practice Guideline for Limb Salvage or Early Amputation
• DIR MODELS OF COLLABORATION AND INTERVENTION BETWEEN PRIMARY CARE AND MENTAL HEALTH IN THE CARE OF PATIENTS DIAGNOSED WITH DEPRESSION: RESULTS OF A META-REVIEW
• DIR Music interventions for dental anxiety in paediatric and adult patients (Best Practice 15(2))
• DIR Olanzapina — Transtorno Afetivo Bipolar
• DIR Opioides fortes (fentanila, oxicodona e buprenorfina) — Dor crônica
• DIR Oral hygiene care for adults with dementia in residential aged care facilities (Best Practice 8(4))
• DIR Palliative approach to care for people with advanced dementia (Best Practice 15(5))
• DIR Palliative care for adults: strong opioids for pain relief
• DIR Palmitato de paliperidona — Esquizofrenia
• DIR Perinatal mental health conditions (SIGN CPG 169)
• DIR Preventing suicide in community and custodial settings
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Comportamento Agressivo no Transtorno do Espectro do Autismo
• DIR Protocolo Clínico e Diretrizes Terapêuticas — Transtorno do Déficit de Atenção com Hiperatividade (TDAH)
• DIR Psychosis and schizophrenia in adults
• DIR Psychosis and schizophrenia in adults: prevention and management
• DIR Psychosis and schizophrenia in children and young people: recognition and management
• DIR Quetiapina — Transtorno Afetivo Bipolar
• DIR Recommandation sur l’utilisation d’un instrument de dépistage de la dépression chez les adultes
• DIR Recommendations on screening for depression in adults
• DIR RELATIONSHIP BETWEEN USE OF CANNABIS AND OTHER DRUGS AND PSYCHIATRIC PATHOLOGY IN ADOLESCENTS. A PROPOSAL OF INPATIENT AND OUTPATIENT MENTAL HEALTH CARE IN THE BASQUE HEALTH SERVICE
• DIR Risperidona — Dependência de cocaína/crack
• DIR Risperidona — Transtorno Afetivo Bipolar
• DIR Risperidona — Transtorno do Espectro do Autismo (TEA)
• DIR Risperidona no comportamento agressivo — Adultos com transtornos do espectro do autismo (TEA)
• DIR Screening for psychosocial distress
• DIR Self-harm: assessment, management and preventing recurrence
• DIR Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health services
• DIR Service user experience in adult mental health services
• DIR Social anxiety disorder: recognition, assessment and treatment
• DIR STUDY OF RISK FACTORS IN SUICIDAL CONDUCT. HEALTH CARE ANALYSIS
• DIR Sucide and Non-Suicidal Self-injury in Chidlren and Adolescents; an evidence based clinical practice guideline
• DIR Suicide prevention
• DIR The best evidence for assisted bathing of older people with dementia (Best Practice 17(3))
• DIR The Effectiveness of Individual Therapy and Group Therapy in the Treatment of Schizophrenia (Best Practice 3(4))
• DIR The long-term efficacy of psychotherapy, alone or in combination with antidepressants, in the treatment of adult major depression
• DIR The National Dementia Guidelines
• DIR The perception and experience of stigma among people with schizophrenia (Best Practice 16(4))
• DIR THERAPEUTIC STRATEGIES IN REFRACTORY SCHIZOPHRENIA OR TREATMENT RESISTANT SCHIZOPHRENIA
• DIR Transition between inpatient mental health settings and community or care home settings
• DIR Transition between inpatient mental health settings and community or care home settings
• DIR Transtorno Afetivo Bipolar do Tipo I
• DIR Transtorno do Déficit de Atenção com Hiperatividade - TDAH
• DIR Unipolar depression – German National Disease Management Guideline
• DIR Update of the Australian Guidelines for the treatment of Acute Stress Disorder and Posttraumatic Stress Disorder
• DIR Violent and aggressive behaviours in people with mental health problems
• DIR WHO guidelines on mental health at work

Documentos para Download:

• DIR Comparison of PET/CT and PET/MR Imaging in Oncology 16v2
• DIR Computerised axial tomography: equipments and use in the ACBC. Instructions on the appropriate use of CAT
• DIR CONGRESS OF NEUROLOGICAL SURGEONS SYSTEMATIC REVIEW AND EVIDENCE-BASED GUIDELINES FOR THE ROLE OF IMAGING FOR PATIENTS WITH FUNCTIONING PITUITARY ADENOMAS
• DIR Evaluation of the utility and indication of prostate biopsies with image fusion – magnetic resonance and transrectal ultrasound
• DIR HIFU —High intensity focused ultrasound— in essential tremor
• DIR Indications, utility and use of ultrasound in primary care
• DIR Magnetic resonance-compatible pacemakers
• DIR Magnetic Resonance Imaging for Pre-Treatment Local Staging of Prostate Cancer 27-3
• DIR Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer 27-2v2
• DIR Patients experience of high technology medical imaging, and interventions to improve it (Best Practice 16(8))
• DIR Preoperative Breast Magnetic Resonance Imaging Guideline 1-25
• DIR Systematic Review and Evidence-Based Guidelines Update for the Role of Imaging in the Management of Patients with Vestibular Schwannomas
• DIR Teste de detecção em soro de anticorpos anti-aquaporina 4 por imunofluorescência indireta em ensaio baseado em células — Pacientes com apresentação clínica-radiológica do distúrbio do espectro da neuromielite óptica
• DIR When not to order chest X-ray

Documentos para Download:

• PDF Radioterapia Hipofracionada Em Câncer de Próstata
• PDF Tumores primários de sistema nervoso central – tratamento com radioterapia de intensidade modulada
• PDF Tumores ginecológicos – tratamento com radioterapia
• PDF Tumores de reto e canal anal – tratamento com radioterapia de intensidade modulada
• PDF Tumores metastáticos de sistema nervoso central – tratamento com radiocirurgia
• PDF Câncer de pulmão – tratamento com radioterapia de intensidade modulada (imrt)
• PDF Câncer de mama -tratamento com radioterapia de intensidade modulada (imrt)
• PDF Tumores ósseos e de partes moles de membros – tratamento com radioterapia externa conformada e com intensidade modulada (imrt)
• PDF Tumores da cabeça e pescoço – tratamento com radioterapia de intensidade modulada (imrt)
• PDF Tumores abdominais – tratamento com radioterapia
• PDF Câncer da próstata – tratamento com radioterapia de intensidade modulada (imrt)
• PDF Câncer de próstata – tratamento com braquiterapia
• DIR An evaluation of intensity-modulated radiotherapy (IMRT)
• DIR Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario 21-6
• DIR QUALITY CONTROL IN INTENSITY MODULATED RADIOTHERAPY
• DIR Systematic Review And Evidence-Based Guideline On The Role Of Radiosurgery (SRS) and Radiation Therapy in the Management of Patients with Vestibular Schwannomas: Updates
• DIR Systematic Review and Evidence Based Guideline on Surgical Resection for the Treatment of Patients with Vestibular Schwannomas: Update